He Eye Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04601701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

He Eye Hospital

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 8
  • # of Trial APIs: 7